Wife convicted of poisoning husband with nicotine in South Korea

Aug.29.2022
Wife convicted of poisoning husband with nicotine in South Korea
A Korean man died from nicotine poisoning, and his wife was suspected of intentionally feeding him the substance.

On a morning in May 2021, a Korean man named A unexpectedly passed away in his home at approximately 7 a.m. After conducting an autopsy, it was determined that the cause of death was nicotine poisoning. As a result, A's wife, B, was named as a suspect in a criminal investigation by the authorities.


Miancha, baizhou, and nicotine solution.


According to reports, A had left work early the day before his death because he was feeling unwell. In a conversation with his wife, B, she informed him that the cause of his illness might have been the expired honey added to his breakfast tea. A was taken to the emergency room shortly after returning home and underwent simple tests and rest before being discharged. He then passed away the following day.


According to the prosecution and the police, it has been suggested that the amount of nicotine found in A's body and their dietary intake indicate that B fed A liquid nicotine three times. It has been reported that B gave A tea containing nicotine in the morning, rice soup containing nicotine when he returned home, and water mixed with liquid nicotine after A returned from the emergency room.


The wife stated that there was no reason to kill her husband.


B claims that "this is a medical accident, she did not kill her husband, and there was no reason for her to do so." The police presented evidence that B had purchased nicotine liquid from a nearby vape shop a few days before the incident. B initially stated that she had bought it for her husband who smoked. However, after investigating the people around A and her credit card usage, the police discovered that A quit smoking eight years ago. B then changed her story and claimed that she had bought the liquid for herself to smoke.


Furthermore, B claims that her husband, A, attempted suicide several months ago and that suicide-related search terms were found on his phone. During this same time, B was involved in a long-term extramarital affair with another man while also accumulating debts exceeding 100 million Korean won.


Most people in the area reported that A's husband also became aware of this fact and, as a result, the couple had a serious argument. The husband also has over 100 million Korean won in life insurance.


According to the judiciary department, the motive for B's murder, which included adultery and debt, was deemed sufficient.


The judiciary department believes that B has a criminal motive.


Firstly, B, the wife, revealed that she had conflicts with her husband in order to maintain a long-term relationship with her lover. If her husband were to die, it would solve her financial difficulties. Furthermore, information left behind by A indicated that he worked hard to support himself and his beloved son, in addition to his profession. There is no reason to believe that he would have made such an extreme choice, given the absence of a suicide note.


In the end, B was sentenced to 30 years in prison and is currently serving the sentence.


Disclaimer: 1. This article is compiled from third-party sources and is only intended for industry communication and learning purposes. 2. The views expressed in this article do not represent those of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity or accuracy of the article's content. The compilation of this article is only intended for industry communication and research purposes. 3. Due to the limited level of compilation, the compiled article may not express exactly the same meaning as the original. Please refer to the original article for accuracy. 4. 2FIRSTS maintains complete consistency with the Chinese government on any statement or position pertaining to domestic, Hong Kong, Macao, and Taiwan, as well as foreign issues. 5. The copyright for the compiled information belongs to the original media and the authors. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

ITGA Unites Global Tobacco Growers at InterTabac / InterSupply 2025
ITGA Unites Global Tobacco Growers at InterTabac / InterSupply 2025
At InterTabac/InterSupply 2025 in Dortmund, ITGA gathered growers from four continents to address market trends, regulation, and sustainability. The AGM reaffirmed ITGA’s mission to secure farmers a living income and highlighted the need for grower-led advocacy to ensure fairness, transparency, and resilience in the global tobacco sector.
Sep.23
From ‘Exclusive Elf Bar Relationship’ to a $20 Million Black Hole: The Unraveling of a U.S. Vape Startup
From ‘Exclusive Elf Bar Relationship’ to a $20 Million Black Hole: The Unraveling of a U.S. Vape Startup
Two Florida-based vape companies, Elf Group LLC and Super Scientific LLC, have filed a lawsuit against their former manager, Tzvie Jakob, accusing him of fabricating transactions, embezzling funds, and misappropriating company resources, with damages exceeding $20 million. According to the complaint, the companies were originally established based on Jakob’s claim of an “exclusive relationship” with Elf Bar, a popular brand he said would provide business opportunities. Investors contributed more
Aug.28
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan Factory Posts Recruitment Notice for Production Positions
QISI’s Dongguan factory has posted new production job openings, following earlier reports of a shutdown at its Zhuhai site.
Oct.15
InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
InterTabac 2025 Insights|Germany’s Leading Distributor E-ZIGARETTEN-HANDELDE Reprises ELFBAR Core Lineup, With Open Systems Dominating
At InterTabac 2025, Germany’s leading distributor E-ZIGARETTEN-HANDELDE again centered its exhibit on ELFBAR, keeping the same booth location and visual identity as in previous years, and handing out tote bags at the hall entrance—creating “walking billboards.” The display focused primarily on open-system products, complemented by pod systems and e-liquids, plus a small selection of open-system lines from other brands.
Sep.20 by 2FIRSTS.ai
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
Iowa E-Cigarette Law Challenged: Industry Claims New Rules Will Destroy the Industry and Violate FDA Enforcement Discretion
E-cigarette sellers and buyers asked the Eighth Circuit Court to keep blocking Iowa's HF 2677 bill. The bill would make all e-cigarettes sold in Iowa get FDA approval. They say the federal Food, Drug, and Cosmetic Act blocks this law, as it steps on FDA's toes by adding penalties where FDA didn't act. If the bill goes through, businesses might close and people could lose tools to quit smoking.
Aug.28 by 2FIRSTS.ai
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International's subsidiary, Transcend Biopharma, has its ANDA accepted by the FDA, potentially granting it 180 days of market exclusivity
Smoore International announced that the U.S. FDA has accepted the Abbreviated New Drug Application (ANDA) for its Breo® Ellipta® 100/25 generic drug, submitted by its wholly-owned subsidiary, Transpire Bio. Transpire Bio stated that if approved, it is expected to receive 180 days of market exclusivity. In the United States, Breo® Ellipta® is already approved for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Sep.25 by 2FIRSTS.ai